Solriamfetol, a dopamine-norepinephrine reuptake inhibitor, improves excessive daytime sleepiness in OSA regardless of primary OSA therapy adherence.
Your search for major depressive disorder returned 130 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Globally, among health care workers, there has been a high prevalence of depression, anxiety, and PTSD during the COVID-19 pandemic.
A team of researchers sought to investigate the bidirectional relationship between multiple sclerosis and major depressive disorder with Mendelian randomization.
More than half of individuals with prior COVID-19 illness have met the criteria for symptoms of major depressive disorder.
Researchers from Dalhousie University in Canada searched publication databases through September of 2020 for articles on ADHD, attention deficit disorder, bipolar disorder, and affective psychosis.
Researchers set out to evaluate whether propranolol efficacy is greater in people with comorbid migraine compared with those without migraine.
Study investigators sought to determine if galcanezumab would reduce not only the frequency of migraine days but also the disabling nonpain symptoms of episodic and chronic migraine.
The goals of this study were to identify functional connectome fingerprints that predict symptom improvement with any treatment and with specific treatment.
A team of researchers sought to evaluate the potential of virtual reality technologies for rehabilitation of patients with Duchenne muscular dystrophy.
This study explores the issue of suicidality in children and youth with epilepsy and psychiatric comorbidities.
The researchers analyzed data from a large randomized noninferiority trial that compared theta-burst stimulation and high-frequency (10 Hz) rTMS delivered to the left dorsolateral prefrontal cortex.
The objective of this post hoc analysis is to better assess the benefits of fremanezumab in patients who responded to treatment during 2 phase 3 HALO clinical trials.
Recently updated diagnostic criteria for fibromyalgia that reduce the underdiagnosis in men had not been implemented during these studies.
With little being known about the predictors or moderators of dTMS outcome for OCD, this study sought to examine if several theoretically relevant variables may predict and moderate treatment effects including OCD symptom severity, functional impairment, co-occurring depressive symptoms, age, gender, age of OCD onset, and family history of OCD.
This study addresses the question of whether prescription opioid medications has a potentially causal role in the risk for depression and anxiety disorder.
Longitudinal changes in the dopamine transporter availability may identify patients with idiopathic REM sleep behavior disorder who are at risk of conversion to neurodegenerative diseases.
Edoxaban was found to be superior to placebo for the prevention of stroke and systemic embolism in very elderly Japanese patients with nonvalvular atrial fibrillation.
Researchers looked to further connect the dots between cognitive behavioral therapy for insomnia and repetitive negative thinking.
Can pain intensity scores predict psychosocial outcomes longitudinally? This study examines that question.
While statins have both good and bad outcomes in the realm of neuropsychiatry, researchers looked at the possible associations with statins and suicidality, depression, anxiety, and seizures.
In patients with dementia, pain is a correlate or prodromal symptom rather than a direct cause of dementia.
Investigating whether serial ketamine treatments change functional connectivity between limbic structures and resting-state networks.
Exploring the risk of alcohol use disorders in patients with insomnia.
Proinflammatory cytokines, tryptophan catabolites, and the gut-brain axis may have key roles in chronic fatigue and depression in patients with multiple sclerosis.
The comorbidity of depressive disorders and late-life neurodegenerative diseases including Alzheimer disease has been widely reported. This study looks into whether there is a causal relationship existing between both or, if their co-occurrence is due to confounding or common risk factors, such as aging.
Examining the potential shared genetic liability of sleep deficits and cannabis use behaviors using multiple genomic methods.
Adults with chronic subjective tinnitus who receive treatment with a device that combines sound and tongue stimulation may experience a significant reduction in tinnitus symptom severity.
Researchers performed a double-blind randomized study to investigate the efficacy of tDCS as an augmentation strategy to sertraline in the treatment of vascular depression.
This study highlights the importance of transdiagnostic approaches to psychiatry.
A photoplethysmography biosensor present in millions of smartphones could potentially be approved by the FDA for pulse oximetry monitoring.
Latest News Your top articles for TuesdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses